Viewing Study NCT07210632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-04-21 @ 12:44 PM
Study NCT ID: NCT07210632
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-10-15
First Post: 2025-09-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Sponsor: Eben Rosenthal
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain Cancer View
None HGG View
None Glioma View
None High Grade Glioma View
None High Grade Gliomas View
None High Grade Glioma (III or IV) View
None High Grade Glioma (HGG) of the Brain With BRAF Aberration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hgg View
None high grade glioma View